Medical consult: aHUS, TTP? How to distinguish and what to do

We present an evidence-based approach to the initial (first 24 hours) diagnosis and management of iTTP and review the clinical and laboratory features that can be used to identify patients with aHUS who will benefit from early C5 blockade. We also discuss the potential use of complement blockade to improve outcomes in selected patients with secondary TMA.PMID:38066937 | PMC:PMC10727109 | DOI:10.1182/hematology.2023000501
Source: Hematology ASH Education Program - Category: Hematology Authors: Source Type: research